Quantcast

Latest Sanofi Pasteur Stories

2014-08-13 16:26:23

- Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older - LYON, France, Aug. 13, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone(®) High-Dose (Influenza Vaccine)...

2014-07-22 08:32:20

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season - SWIFTWATER, Pa., July 22, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone(®) (Influenza Vaccine) for the 2014-2015 influenza ("the flu") season have been released by the U.S. Food and Drug...

2014-07-01 08:31:10

- Triggered by ongoing and very successful multi-year collaboration TUBINGEN, Germany, July 1, 2014 /PRNewswire/ -- CureVac, a German clinical-stage biopharmaceutical company, today announced the execution of an exclusive license agreement with Sanofi Pasteur S.A., the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), to develop and commercialize an mRNA-based vaccine against an undisclosed pathogen. In 2011, CureVac and Sanofi Pasteur signed a collaboration and license...

2014-06-30 12:26:36

MONTREAL, June 30, 2014 /CNW Telbec/ - For more than 75 youngsters with life-threatening allergies, participating in a soccer clinic hosted by the Montreal Impact and Allerject(TM) was a dream come true. For an hour and a half on Sunday, June 29, the kids were put through their paces by the club's official Soccer Schools. "This event demonstrated to these young people that, with proper precaution and preparation - that they do not have to be defined by their allergies," says...

2014-06-16 23:03:25

Transparency Market Research published a new report "Meningococcal Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to its report store. Browse the full report: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html. Albany, New York (PRWEB) June 16, 2014 According to a new report published by Transparency Market Research "Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines,...

2014-05-19 08:28:22

Results indicate vaccine generates an immune response against key toxins in volunteers and establish dosing for Phase III BOSTON, May 19, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), presented Phase II trial (H-030-012) results for an investigational vaccine for the prevention of Clostridium difficile (C. diff) infection (CDI) at the 114th General Meeting of the American Society for Microbiology (ASM). The Phase II trial met its...

2014-05-12 08:32:05

Olympic Medalist swimmer and mother, Dara Torres, and the National Association of School Nurses launch multi-city health initiative as part of Voices of Meningitis(TM) SILVER SPRING, Md. and SWIFTWATER, Pa., May 12, 2014 /PRNewswire/ -- Although meningococcal meningitis is a rare but serious disease that can potentially take a life in 24 hours,(1) a national survey revealed that more than two in three mothers have little to no knowledge of the Centers for Disease Control and Prevention's...

2014-05-09 08:25:36

ALBANY, New York, May 9, 2014 /PRNewswire/ -- According to a new report published by Transparency Market Research "Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the market for meningococcal vaccines was valued at USD 1.5 billion in 2012 and is expected to reach a value of USD 3.7 billion in 2019, growing at a CAGR of 14.9% from...

2014-04-29 08:36:15

PARIS, April 29, 2014 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2014 Change (reported) Change (CER) Net sales EUR7,842m -2.7% +3.5% Business net income(2) EUR1,547m -3.2% +5.6% Business EPS(1) EUR1.17 -3.3% +5.8% -------------- ------- ---- ---- In order to facilitate an understanding of our operational...

2014-04-01 08:30:35

Approval reinforces the safety profile of Adacel as an active booster immunization for the prevention of tetanus, diphtheria, and pertussis SWIFTWATER, Pa., April 1, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel(®) (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related